Coronary artery disease is the number one killer in Australia
Know your risk. To reduce your risk.
Do you know which factors influence your risk of coronary artery disease?
Coronary artery disease is largely preventable2
It is with a comprehensive risk assessment that you and your health provider may be able to enable effective management of modifiable risk factors.1
Is geneType™ for Coronary Artery Disease right for you?
GeneType for Coronary Artery Disease is appropriate for:
- Adults 40-85 years old
Simple, actionable results
geneType™ reports help you and your health provider translate your personal clinical, family and genetic data into an actionable preventable health plan.
Unlike other tests, your test results are provided in simple language that you can understand.
Key features of the report:
- 10-year risk score your health provider may use to tailor risk-reducing recommendations for you
- Recommendations based on the latest AAC/AHA guidelines
Sample patient report
Personalised risk score. Personalised health plan.
Risk reducing options exist for adults at borderline, intermediate and high risk of coronary artery disease.
Have questions? We have answers.
If your question is not shown here, please contact us directly.
Is this test reimbursed by insurance?
No. At this time geneType™ is a self-pay test. However, you may use FSA/HSA to pay for the test.
Does this test cover all the coronary artery disease risk factors?
Coronary artery disease is a multifactorial disease and it is not possible to incorporate all potential risk factors into a risk prediction model. Test results should be interpreted by a health provider in the context of your clinical and family history.
I bought a different test online and it is showing I had a high polygenic risk of coronary artery disease, should I retest with geneType™?
Yes.
While there are other companies out there that provide random lists of genetic markers that are associated with coronary artery disease, there are no checks and balances associated with the results they provide. Most of the markers they pull from peer-reviewed publications without cross validating the markers. And more importantly, geneType goes through rigorous statistical validation of the genetic component prior to integrating it into the full model. The fully integrated geneType model is then validated separately.
Know your risk of coronary artery disease so you can take action
*Patient eligibility dependent on personal medical history, age and sex
Interested in ordering more than one disease? Order geneType™ Multi-Test.
The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for eight diseases in the panel; a man would be eligible for seven. Starting at age 30, a patient may qualify for geneType's™ cancer risk assessments only.
References
1. John Hopkins Medicine. Coronary Artery Disease: Prevention, Treatment and Research. Accessed June 2022.
2. Fryar CD et al. NCHS Data Brief 2012(103):1-8.
Accredited For Compliance With NPAAC Standards And ISO 15189
